Table: Fuji Pharmaceutical - 9-MTH group results

Fuji Pharma

07/08/2025 08:30

Aug 7 (Reuters)- 
             Fuji Pharmaceutical  Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 9 months ended      9 months ended       Year to 
                Jun 30, 2025        Jun 30, 2024     Sep 30, 2025 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             36.95               33.16            53.36    
                 (+11.5 pct)         (+12.5 pct)      (+15.7 pct) 
  Operating          3.37                2.22             4.85    
                 (+52.0 pct)         (-7.8 pct)       (+25.0 pct) 
  Recurring          3.16                2.97             4.68    
                 (+6.4 pct)          (+8.3 pct)       (+5.3 pct)  
  Net                1.83                4.91             3.38    
                 (-62.7 pct)        (+147.7 pct)      (-45.0 pct) 
  EPS             75.07 yen          201.98 yen       139.07 yen  
  Ann Div                             42.50 yen        45.50 yen  
  -Q2 div         20.00 yen           20.00 yen                   
  -Q4 div                             22.50 yen        25.50 yen  
  
  NOTE - Fuji Pharmaceutical  Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4554.T